|
||
| |||||||
|
|
St.
Louis, MO,
and Taufkirchen, Germany, 24th February 2006 –
Sigma-Aldrich, (NASDAQ: SIAL) a leading $1.7 billion
Life Science company, is pleased to announce the latest addition to its
Panorama™ Protein Array product line, the Panorama™ Human Kinase v1
Array. Developed in conjunction with Procognia Ltd, UK, and licensed
exclusively through Sigma-Aldrich, the Kinase v1 protein array contains
152 commonly studied kinases. This array employs a unique fusion tag
attached to each kinase that serves to tether and uniformly orientate
proteins on the array surface, and has been shown to confer kinase
functionality. This technology offers the unique advantage that allows
proteins to behave in a sterically unencumbered manner on the array and
potentially result in more physiologically relevant data.
“Kinases represent a
significant group of proteins within the druggable proteome and, thus,
are the focus of substantial drug discovery efforts in most therapeutic
areas within pharmaceutical and biotech companies, as well as academia,”
said Michael Hadjisavas, Global Strategic Marketing Manager for
Proteomics and Cell Biology. “Given the growing and pivotal importance
of kinases in virtually every cellular function, a dire need has emerged
among researchers to study the ‘kinome’ in a multiplex array format. By
providing a themed array of commonly studied kinases, researchers can
study the function of this key protein family by performing multiplex
assays for selectivity profiling with other proteins, antibodies,
peptides, kinases and drug candidates.”
The Panorama Human Kinase v1
Array extends Sigma-Aldrich’s market-leading array portfolio for
proteomic research, including arrays of proteins, antibodies, peptides
and tissue extracts. Information on this array, as well as
Sigma-Aldrich’s full line of array-related products for proteomics, can
be found at
http://sigma-aldrich.com/hpfm3.
About Sigma-Aldrich:
Sigma-Aldrich is a leading
Life Science and High Technology company. Our
biochemical and organic chemical products and kits are used in
scientific and genomic research, biotechnology, pharmaceutical
development, the diagnosis of disease and as key components in
pharmaceutical and other high technology manufacturing. We have
customers in life science companies, university and government
institutions, hospitals, and in industry. Over one million scientists
and technologists use our products. Sigma-Aldrich operates in 35
countries and has over 6,800 employees providing excellent service
worldwide. We are committed to accelerating Customer success through
leadership in Life Science, High Technology and Service.
For more information
about Sigma-Aldrich, please visit our award-winning Web site at
www.sigma-aldrich.com.
Cautionary Statement:
This release contains forward-looking statements relating to future
performance, goals, strategic actions and initiatives and similar
intentions and beliefs and other statements regarding the Company’s
expectations, goals, beliefs, intentions and the like, which involve
assumptions regarding Company operations and conditions in the markets
the Company serves. The Company does not undertake any obligation to
update these forward-looking statements.
Media enquiries to
Northbank Communications:
Marc Egelhofer, Tel: +44 (0)1260 296505 m.egelhofer@northbankcommunications.com
At Sigma-Aldrich:
Michael Hadjisavas,
+1-314-286-7431
|
|
| ||||||||
